Literature DB >> 26965684

12-HETER1/GPR31, a high-affinity 12(S)-hydroxyeicosatetraenoic acid receptor, is significantly up-regulated in prostate cancer and plays a critical role in prostate cancer progression.

Kenneth V Honn1, Yande Guo2, Yinlong Cai2, Menq-Jer Lee2, Gregory Dyson3, Wenliang Zhang2, Stephanie C Tucker4.   

Abstract

Previously we identified and deorphaned G-protein-coupled receptor 31 (GPR31) as the high-affinity 12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE] receptor (12-HETER1). Here we have determined its distribution in prostate cancer tissue and its role in prostate tumorigenesis using in vitro and in vivo assays. Data-mining studies strongly suggest that 12-HETER1 expression positively correlates with the aggressiveness and progression of prostate tumors. This was corroborated with real-time PCR analysis of human prostate tumor tissue arrays that revealed the expression of 12-HETER1 positively correlates with the clinical stages of prostate cancers and Gleason scores. Immunohistochemistry analysis also proved that the expression of 12-HETER1 is positively correlated with the grades of prostate cancer. Knockdown of 12-HETER1 in prostate cancer cells markedly reduced colony formation and inhibited tumor growth in animals. To discover the regulatory factors, 5 candidate 12-HETER1 promoter cis elements were assayed as luciferase reporter fusions in Chinese hamster ovary (CHO) cells, where the putative cis element required for gene regulation was mapped 2 kb upstream of the 12-HETER1 transcriptional start site. The data implicate 12-HETER1 in a critical new role in the regulation of prostate cancer progression and offer a novel alternative target for therapeutic intervention.-Honn, K. V., Guo, Y., Cai, Y., Lee, M.-J., Dyson, G., Zhang, W., Tucker, S. C. 12-HETER1/GPR31, a high-affinity 12(S)-hydroxyeicosatetraenoic acid receptor, is significantly up-regulated in prostate cancer and plays a critical role in prostate cancer progression. © FASEB.

Entities:  

Keywords:  12(S)-HETE; arachidonate metabolism in malignancy; inflammatory pathway

Mesh:

Substances:

Year:  2016        PMID: 26965684      PMCID: PMC4871796          DOI: 10.1096/fj.201500076

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  71 in total

Review 1.  Lipoxygenase inhibitors as potential cancer chemopreventives.

Authors:  V E Steele; C A Holmes; E T Hawk; L Kopelovich; R A Lubet; J A Crowell; C C Sigman; G J Kelloff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-05       Impact factor: 4.254

2.  Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.

Authors:  Sooryanarayana Varambally; Jianjun Yu; Bharathi Laxman; Daniel R Rhodes; Rohit Mehra; Scott A Tomlins; Rajal B Shah; Uma Chandran; Federico A Monzon; Michael J Becich; John T Wei; Kenneth J Pienta; Debashis Ghosh; Mark A Rubin; Arul M Chinnaiyan
Journal:  Cancer Cell       Date:  2005-11       Impact factor: 31.743

3.  Androgen regulation of ETS gene fusion transcripts in prostate cancer.

Authors:  Delila Gasi; Jan Trapman
Journal:  Methods Mol Biol       Date:  2011

4.  Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunction.

Authors:  David A Taylor-Fishwick; Jessica Weaver; Lindsey Glenn; Norine Kuhn; Ganesha Rai; Ajit Jadhav; Anton Simeonov; Angela Dudda; Dieter Schmoll; Theodore R Holman; David J Maloney; Jerry L Nadler
Journal:  Diabetologia       Date:  2014-11-23       Impact factor: 10.122

5.  Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer.

Authors:  Simona Nanni; Carmen Priolo; Annalisa Grasselli; Manuela D'Eletto; Roberta Merola; Fabiola Moretti; Michele Gallucci; Piero De Carli; Steno Sentinelli; Anna Maria Cianciulli; Marcella Mottolese; Paolo Carlini; Diego Arcelli; Mauro Helmer-Citterich; Carlo Gaetano; Massimo Loda; Alfredo Pontecorvi; Silvia Bacchetti; Ada Sacchi; Antonella Farsetti
Journal:  Mol Cancer Res       Date:  2006-02       Impact factor: 5.852

Review 6.  Lipoxygenase metabolism: roles in tumor progression and survival.

Authors:  Graham P Pidgeon; Joanne Lysaght; Sriram Krishnamoorthy; John V Reynolds; Ken O'Byrne; Daotai Nie; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

7.  Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer.

Authors:  X Gao; D J Grignon; T Chbihi; A Zacharek; Y Q Chen; W Sakr; A T Porter; J D Crissman; J E Pontes; I J Powell
Journal:  Urology       Date:  1995-08       Impact factor: 2.649

8.  Regulation of 12-lipoxygenase in rat intestinal epithelial cells during differentiation and apoptosis induced by sodium butyrate.

Authors:  H Kamitani; H Ikawa; L C Hsi; T Watanabe; R N DuBois; T E Eling
Journal:  Arch Biochem Biophys       Date:  1999-08-01       Impact factor: 4.013

9.  Inhibition of 12/15-lipoxygenase by baicalein induces microglia PPARβ/δ: a potential therapeutic role for CNS autoimmune disease.

Authors:  J Xu; Y Zhang; Y Xiao; S Ma; Q Liu; S Dang; M Jin; Y Shi; B Wan; Y Zhang
Journal:  Cell Death Dis       Date:  2013-04-04       Impact factor: 8.469

10.  Targeting HOX transcription factors in prostate cancer.

Authors:  Richard Morgan; Angie Boxall; Kevin J Harrington; Guy R Simpson; Agnieszka Michael; Hardev S Pandha
Journal:  BMC Urol       Date:  2014-02-05       Impact factor: 2.264

View more
  14 in total

1.  Targeting RAS - will GPR31 deliver us a new path forward?

Authors:  Nicole Fehrenbacher; Mark R Philips
Journal:  Mol Cell Oncol       Date:  2017-07-31

2.  An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury.

Authors:  Xiao-Jing Zhang; Xu Cheng; Zhen-Zhen Yan; Jing Fang; Xiaozhan Wang; Weijun Wang; Zhen-Yu Liu; Li-Jun Shen; Peng Zhang; Pi-Xiao Wang; Rufang Liao; Yan-Xiao Ji; Jun-Yong Wang; Song Tian; Xue-Yong Zhu; Yan Zhang; Rui-Feng Tian; Lin Wang; Xin-Liang Ma; Zan Huang; Zhi-Gang She; Hongliang Li
Journal:  Nat Med       Date:  2017-12-11       Impact factor: 53.440

3.  Lipopeptide Pepducins as Therapeutic Agents.

Authors:  Emily Michael; Lidija Covic; Athan Kuliopulos
Journal:  Methods Mol Biol       Date:  2022

4.  LINE-1 promotes tumorigenicity and exacerbates tumor progression via stimulating metabolism reprogramming in non-small cell lung cancer.

Authors:  Zeguo Sun; Rui Zhang; Xiao Zhang; Yifei Sun; Pengpeng Liu; Nancy Francoeur; Lei Han; Wan Yee Lam; Zhengzi Yi; Robert Sebra; Martin Walsh; Jinpu Yu; Weijia Zhang
Journal:  Mol Cancer       Date:  2022-07-16       Impact factor: 41.444

5.  A 12-lipoxygenase-Gpr31 signaling axis is required for pancreatic organogenesis in the zebrafish.

Authors:  Marimar Hernandez-Perez; Abhishek Kulkarni; Niharika Samala; Cody Sorrell; Kimberly El; Isra Haider; Ansari Mukhtar Aleem; Theodore R Holman; Ganesha Rai; Sarah A Tersey; Raghavendra G Mirmira; Ryan M Anderson
Journal:  FASEB J       Date:  2020-09-12       Impact factor: 5.191

Review 6.  Unraveling the Role of 12- and 20- HETE in Cardiac Pathophysiology: G-Protein-Coupled Receptors, Pharmacological Inhibitors, and Transgenic Approaches.

Authors:  Jonathan V Pascale; Pamela A Lucchesi; Victor Garcia
Journal:  J Cardiovasc Pharmacol       Date:  2021-06-01       Impact factor: 3.271

7.  Evidence that ABC transporter-mediated autocrine export of an eicosanoid signaling molecule enhances germ cell chemotaxis in the colonial tunicate Botryllus schlosseri.

Authors:  Susannah H Kassmer; Delany Rodriguez; Anthony W De Tomaso
Journal:  Development       Date:  2020-08-07       Impact factor: 6.862

8.  The G protein-coupled receptor GPR31 promotes membrane association of KRAS.

Authors:  Nicole Fehrenbacher; Israel Tojal da Silva; Craig Ramirez; Yong Zhou; Kwang-Jin Cho; Shafi Kuchay; Jie Shi; Susan Thomas; Michele Pagano; John F Hancock; Dafna Bar-Sagi; Mark R Philips
Journal:  J Cell Biol       Date:  2017-06-15       Impact factor: 10.539

9.  Antagonizing effects of membrane-acting androgens on the eicosanoid receptor OXER1 in prostate cancer.

Authors:  Konstantina Kalyvianaki; Veronika Gebhart; Nikolaos Peroulis; Christina Panagiotopoulou; Fotini Kiagiadaki; Iosif Pediaditakis; Michalis Aivaliotis; Eleni Moustou; Maria Tzardi; George Notas; Elias Castanas; Marilena Kampa
Journal:  Sci Rep       Date:  2017-03-14       Impact factor: 4.379

Review 10.  A review of non-prostanoid, eicosanoid receptors: expression, characterization, regulation, and mechanism of action.

Authors:  Roger G Biringer
Journal:  J Cell Commun Signal       Date:  2021-06-26       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.